Abstract:The introduction of the bovine (BPV) or human papillomavirus E6 gene into susceptible cells can result in their transformation, but there are few clues to the mechanism of action of the E6 gene. The characteristic features of E6 proteins are their small size (approximately 150 amino acids) and the potential to form two large zinc fingers. To determine if E6 can function as a transcription factor, the BPV E6 gene was fused to the sequence specific DNA binding peptide encoded by the BPV E2 gene. This chimeric E6… Show more
“…The results shown are the lacZ activity relative to that obtained with wild-type lexA-BE6 fusion. Because BE6-lexA fusions have endogenous transcriptional activation properties which are altered in BE6 mutants (Lamberti et al, 1990), OD405 values obtained in cultures expressing the empty B42-fusion vector alone were substracted from values obtained in the presence of B42-E6-AP or B42-paxillin fusions, to more closely approximate the lacZ activity resulting from the interaction of lexA-BE6 with E6-AP or paxillin. Transformation results re¯ect the induction of anchorage independent growth in nobel agar by BE6 mutants relative to wild-type BE6.…”
We have found that the E6 oncoprotein of Bovine Papillomavirus Type 1 (BE6) as well as the E6 protein of the cancer associated HPV-16 (16E6) interact with the focal adhesion protein paxillin. Mutational analysis of paxillin revealed that BE6 binds paxillin through small protein interaction motifs called LD motifs that have been previously identi®ed as important in regulating association of paxillin with vinculin and focal adhesion kinase (FAK), and that BE6 can interact with at least two separate binding sites on paxillin. The LD motifs of paxillin that bind BE6 share homology with the E6 binding site of E6-AP, a ubiquitin ligase that together with 16E6 targets the degradation of the p53 tumor suppressor. Paxillin binding to BE6 excludes simultaneous binding to E6-AP. Mutational analysis of BE6 can distinguish the interaction of BE6 with E6-AP compared to paxillin and revealed that the interaction of BE6 with paxillin may be necessary for the induction of anchorage independent growth of cells by BE6.
“…The results shown are the lacZ activity relative to that obtained with wild-type lexA-BE6 fusion. Because BE6-lexA fusions have endogenous transcriptional activation properties which are altered in BE6 mutants (Lamberti et al, 1990), OD405 values obtained in cultures expressing the empty B42-fusion vector alone were substracted from values obtained in the presence of B42-E6-AP or B42-paxillin fusions, to more closely approximate the lacZ activity resulting from the interaction of lexA-BE6 with E6-AP or paxillin. Transformation results re¯ect the induction of anchorage independent growth in nobel agar by BE6 mutants relative to wild-type BE6.…”
We have found that the E6 oncoprotein of Bovine Papillomavirus Type 1 (BE6) as well as the E6 protein of the cancer associated HPV-16 (16E6) interact with the focal adhesion protein paxillin. Mutational analysis of paxillin revealed that BE6 binds paxillin through small protein interaction motifs called LD motifs that have been previously identi®ed as important in regulating association of paxillin with vinculin and focal adhesion kinase (FAK), and that BE6 can interact with at least two separate binding sites on paxillin. The LD motifs of paxillin that bind BE6 share homology with the E6 binding site of E6-AP, a ubiquitin ligase that together with 16E6 targets the degradation of the p53 tumor suppressor. Paxillin binding to BE6 excludes simultaneous binding to E6-AP. Mutational analysis of BE6 can distinguish the interaction of BE6 with E6-AP compared to paxillin and revealed that the interaction of BE6 with paxillin may be necessary for the induction of anchorage independent growth of cells by BE6.
“…BPV-1 E6 stimulates transcription when targeted to a promoter (Lamberti et al, 1990), although cellular promoters responsive to BPV-1 E6 have not been identi®ed. Mutational analysis indicated that the transcriptional activation function of BPV-1 E6 is not su cient for cell transformation (Chen et al, 1997;Ned et al, 1997).…”
“…The intrinsic binding affinity of HPV-16 E6 and E7 to the cellular tumour suppressors p53 and pRb, and the modulation of their expression by the LCR as well as by the P *( promoter, derepressed by the disruption of E2 during HPV integration into the cellular genome, have been correlated with their oncogenic properties in the pathogenesis of neoplasia of the female lower genital tract (Dyson et al, 1989 ;Werness et al, 1990 ;Scheffner et al, 1993Scheffner et al, , 1995Lambert & Howley, 1988 ;Lamberti et al, 1990 ;Schiller et al, 1989).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.